Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v16-EN
Language English English
Date Updated 2019-06-01 2019-06-01
Drug Identification Number 02241933 02241933
Brand name VIOKACE VIOKACE
Common or Proper name VIOKACE 20880 VIOKACE 20880
Company Name NESTLE ENTERPRISES S.A. NESTLE ENTERPRISES S.A.
Ingredients AMYLASE PROTEASE LIPASE AMYLASE PROTEASE LIPASE
Strength(s) 113400UNIT 112500UNIT 20880UNIT 113400UNIT 112500UNIT 20880UNIT
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100's count bottle 100's count bottle
ATC code A09AA A09AA
ATC description DIGESTIVES, INCL ENZYMES DIGESTIVES, INCL ENZYMES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-03-08 2019-03-08
Actual start date 2019-03-05 2019-03-05
Estimated end date 2019-06-21 2019-06-21
Actual end date 2019-05-31 2019-05-31
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Delay with Viokase 20880 (SKU 20494) product release and raw material replenishment. Viokace 10440 (SKU 20495) remains available to alleviate impact. Delay with Viokase 20880 (SKU 20494) product release and raw material replenishment. Viokace 10440 (SKU 20495) remains available to alleviate impact.
Health Canada comments